Skip to content


Sivextro (tedizolid) is a small molecule pharmaceutical. Tedizolid was first approved as Sivextro on 2014-06-20. It is used to treat bacterial infections, bacterial skin diseases, staphylococcal infections, and streptococcal infections in the USA. It has been approved in Europe to treat bacterial skin diseases and soft tissue infections. Sivextro's patents are valid until 2030-12-31 (FDA).
Trade Name Sivextro
Common Name Tedizolid
Indication bacterial infections, bacterial skin diseases, soft tissue infections, staphylococcal infections, streptococcal infections
Drug Class Oxazolidinone antibacterials
Get full access now